Meike Adam

Hamburg, HH, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Marked Prognostic Impact of Minimal Lymphatic Tumor Spread in Prostate Cancer.

Marked Prognostic Impact of Minimal Lymphatic Tumor Spread in Prostate Cancer.

Journal: European urology

Published: October 16, 2017

High concordance of findings obtained from transgluteal magnetic resonance imaging - and transrectal ultrasonography-guided biopsy as compared with prostatectomy specimens.

High concordance of findings obtained from transgluteal magnetic resonance imaging - and transrectal ultrasonography-guided biopsy as compared with prostatectomy specimens.

Journal: BJU international

Published: March 16, 2017

Correction: Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer.

Correction: Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer.

Journal: Oncotarget

Published: February 02, 2017

Functional Outcomes and Quality of Life After Radical Prostatectomy Only Versus a Combination of Prostatectomy with Radiation and Hormonal Therapy.

Functional Outcomes and Quality of Life After Radical Prostatectomy Only Versus a Combination of Prostatectomy with Radiation and Hormonal Therapy.

Journal: European urology

Published: July 29, 2016

Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer.

Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer.

Journal: Carcinogenesis

Published: July 28, 2016

Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer.

Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer.

Journal: Oncotarget

Published: May 27, 2015

High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer.

High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer.

Journal: PloS one

Published: April 28, 2015

Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletion.

Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletion.

Journal: Oncology reports

Published: April 07, 2015

The Combination of DNA Ploidy Status and PTEN/6q15 Deletions Provides Strong and Independent Prognostic Information in Prostate Cancer.

The Combination of DNA Ploidy Status and PTEN/6q15 Deletions Provides Strong and Independent Prognostic Information in Prostate Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 19, 2015

HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy.

HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy.

Journal: Oncotarget

Published: January 16, 2015

Concurrent deletion of 16q23 and PTEN is an independent prognostic feature in prostate cancer.

Concurrent deletion of 16q23 and PTEN is an independent prognostic feature in prostate cancer.

Journal: International journal of cancer

Published: November 12, 2014

Interstitial lung disease during targeted therapy in metastatic renal cell carcinoma: a case series from three centres.

Interstitial lung disease during targeted therapy in metastatic renal cell carcinoma: a case series from three centres.

Journal: Medical oncology (Northwood, London, England)

Published: April 22, 2014

Showing 1-12 of 26

Last Updated: 09/26/2026